Tianjin, China

Junjie Cong

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junjie Cong. Retrieved from https://idiyas.com/inventor/junjie-cong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junjie Cong - Innovator in Cancer Treatment

Introduction

Junjie Cong is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Junjie Cong holds a patent for Pyridyl cyanoguanidine derivatives. This patent includes compounds of formula (I) or pharmaceutically acceptable salts thereof, which are disclosed for their use in treating cancer. The definitions of X, Y, R, and n are described in detail within the patent description, highlighting the complexity and potential of his work.

Career Highlights

Throughout his career, Junjie Cong has focused on research and development in the pharmaceutical industry. His innovative approach has led to the successful patenting of his work, which is a testament to his skills as an inventor. His contributions are paving the way for new treatments that could benefit many patients suffering from cancer.

Collaborations

Junjie Cong has collaborated with notable colleagues in his field, including Xin Chen and Hesheng Zhang. These partnerships have allowed for a sharing of ideas and expertise, further enhancing the quality and impact of his research.

Conclusion

Junjie Cong is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in pharmaceuticals. His patent for Pyridyl cyanoguanidine derivatives represents a significant step forward in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…